Related Experiment Video
Updated: Sep 27, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion
C Hvarfner1, A Hillarp, J Larsson
1Department of Ophthalmology, Lund University Hospital, 211 85 Lund, Sweden. charlotte.hvarfner@oft.lu.se
Aims:
To investigate if the presence of factor V Leiden has an influence on the prognosis in central retinal vein occlusion (CRVO).
Methods:
166 patients with CRVO were studied retrospectively. They were tested for factor V Leiden using DNA analysis. The presence of the mutation was studied in correlation with the development of neovascular complications 1 year after the thrombotic event.
Results:
56 of 166 patients (34%) developed neovascular complications after 1 year. In the patients who had the studied mutation 11 of 20 (55%) had developed neovascular complications after 1 year, compared to 45 of 146 patients (31%) in the group without factor V Leiden (p=0.04).
Conclusion:
The presence of factor V Leiden seems to enhance the risk of developing neovascular complications in CRVO.
Related Concept Videos
Diabetic Retinopathy
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Regulation of Angiogenesis and Blood Supply
Venous Thrombosis III: Interprofessional Care
Varicose Veins I: Introduction
